 |
| Rachel Gartner Clark |
Rachel Gartner Clark, who led Real Chemistry’s public affairs practice, is joining Narrative Strategies as managing director, overseeing the agency’s healthcare practice.
At Real Chemistry, she worked with clients to mobilize patient and provider voices with the goal of educating and influencing decision-making at the Food and Drug Administration. She previously worked in the healthcare practices at Weber Shandwick and Edelman.
Gartner Clark also chairs the Patient Advisory Council for the Diabetes Patient Advocacy Coalition and serves on the Community Leadership Board of the American Diabetes Association.
In her new post, she will lead a vertical with clients in the biopharmaceutical, medical technology, and provider sectors.
“Rachel’s ability to lead large-scale healthcare campaigns and her extensive relationships across the industry will make one of Narrative’s strongest areas of issue expertise even stronger,” said Narrative Strategies Founding Partner Ken Spain.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
